A Competitive Inhibitor Traps LeuT in an Open-to-Out Conformation

被引:347
作者
Singh, Satinder K. [1 ]
Piscitelli, Chayne L. [1 ,3 ]
Yamashita, Atsuko [4 ]
Gouaux, Eric [1 ,2 ]
机构
[1] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA
[2] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA
[3] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA
[4] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA
关键词
D O I
10.1126/science.1166777
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Secondary transporters are workhorses of cellular membranes, catalyzing the movement of small molecules and ions across the bilayer and coupling substrate passage to ion gradients. However, the conformational changes that accompany substrate transport, the mechanism by which a substrate moves through the transporter, and principles of competitive inhibition remain unclear. We used crystallographic and functional studies on the leucine transporter ( LeuT), a model for neurotransmitter sodium symporters, to show that various amino acid substrates induce the same occluded conformational state and that a competitive inhibitor, tryptophan ( Trp), traps LeuT in an open- to- out conformation. In the Trp complex, the extracellular gate residues arginine 30 and aspartic acid 404 define a second weak binding site for substrates or inhibitors as they permeate from the extracellular solution to the primary substrate site, which demonstrates how residues that participate in gating also mediate permeation.
引用
收藏
页码:1655 / 1661
页数:7
相关论文
共 36 条
  • [11] Disruption of the taurine transporter gene (taut) leads to retinal degeneration in mice
    Heller-Stilb, B
    van Roeyen, C
    Rascher, K
    Hartwig, HG
    Huth, A
    Seeliger, MW
    Warskulat, U
    Häussinger, D
    [J]. FASEB JOURNAL, 2001, 15 (14) : 231 - +
  • [12] Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants
    Henry, LK
    Field, JR
    Adkins, EM
    Parnas, ML
    Vaughan, RA
    Zou, MF
    Newman, AH
    Blakely, RD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (04) : 2012 - 2023
  • [13] Serotonin and cocaine-sensitive inactivation of human serotonin transporters by methanethiosulfonates targeted to transmembrane domain I
    Henry, LK
    Adkins, EM
    Han, Q
    Blakely, RD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (39) : 37052 - 37063
  • [14] Common mechanisms of inhibition for the Na+/glucose (hSGLT1) and Na+/Cl-/GABA (hGAT1) cotransporters
    Hirayama, BA
    Díez-Sampedro, A
    Wright, EM
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (03) : 484 - 495
  • [15] Structure and function of sodium-coupled GABA and glutamate transporters
    Kanner, Baruch I.
    [J]. JOURNAL OF MEMBRANE BIOLOGY, 2006, 213 (02) : 89 - 100
  • [16] HIGH-AFFINITY UPTAKE OF [H-3]NOREPINEPHRINE BY PRIMARY ASTROCYTE CULTURES AND ITS INHIBITION BY TRICYCLIC ANTI-DEPRESSANTS
    KIMELBERG, HK
    PELTON, EW
    [J]. JOURNAL OF NEUROCHEMISTRY, 1983, 40 (05) : 1265 - 1270
  • [17] GABA uptake inhibitors. Design, molecular pharmacology and therapeutic aspects
    Krogsgaard-Larsen, P
    Frolund, B
    Frydenvang, K
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2000, 6 (12) : 1193 - 1209
  • [18] Masson J, 1999, PHARMACOL REV, V51, P439
  • [19] Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype
    Ozaki, N
    Goldman, D
    Kaye, WH
    Plotnicov, K
    Greenberg, BD
    Lappalainen, J
    Rudnick, G
    Murphy, DL
    [J]. MOLECULAR PSYCHIATRY, 2003, 8 (11) : 933 - 936
  • [20] Transport mechanisms in acetylcholine and monoamine storage
    Parsons, SM
    [J]. FASEB JOURNAL, 2000, 14 (15) : 2423 - 2434